Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHOLL, S. M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Vaccination contre les cellules tumorales mammaires exprimant la mucine MUC1 = Vaccination against the polymorphic epithelial mucine MUC1 commonly overexpressed in breast cancerSCHOLL, S. M; POUILLART, P.Bulletin du cancer. 1997, Vol 84, Num 1, pp 61-64, issn 0007-4551Article

Is colony-stimulating factor-1 a key mediator of breast cancer invasion and metastasis?SCHOLL, S. M; CROCKER, P; RUOPING TANG et al.Molecular carcinogenesis (Print). 1993, Vol 7, Num 4, pp 207-211, issn 0899-1987Article

CSF-1 (Colony stimulating factor 1) et récepteur du CSF-1. Revue générale et expression dans les tumeurs mammaires invasives = CSF-1 (colony stimulating factor 1) and CSF-1 receptor. Review and expression in breast tumour invasionBEUVON, F; PALUD, C; TANG, R et al.Bulletin du cancer. 1993, Vol 80, Num 1, pp 29-35, issn 0007-4551Article

Hormone receptors in rapidly progressing breast cancerLEVINE, P. H; TABBANE, F; MUENZ, L. R et al.Cancer. 1984, Vol 54, Num 12, pp 3012-3016, issn 0008-543XArticle

Analyzing prognostic factors in breast cancer using a multistate modelBROËT, P; DE LA ROCHCFORDIERE, A; SCHOLL, S. M et al.Breast cancer research and treatment. 1999, Vol 54, Num 1, pp 83-89, issn 0167-6806Article

Two distinct cell populations are obtained from human blood monocytes cultured with M-CSF, GM-CSF and IL-4BARON, C. L; SCHOLL, S. M; BAUSINGER, H et al.European journal of cancer. Supplement (1990). 1999, Vol 35, Num 3, pp S39-S40, issn 1359-6349Article

Contralateral breast cancer : annual incidence and risk parametersBROËT, P; DE LA ROCHEFORDIERE, A; SCHOLL, S. M et al.Journal of clinical oncology. 1995, Vol 13, Num 7, pp 1578-1583, issn 0732-183XArticle

Phase ii trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinomaPIERGA, J.-Y; DIERAS, V; BEUZEBOC, P et al.Gynecologic oncology (Print). 1997, Vol 66, Num 2, pp 246-249, issn 0090-8258Conference Paper

Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil : a phase II studyPIERGA, J.-Y; DIERAS, V; PARAISO, D et al.Gynecologic oncology (Print). 1996, Vol 60, Num 1, pp 59-63, issn 0090-8258Conference Paper

Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trialBROËT, P; SCHOLL, S. M; DE LA ROCHEFORDIERE, A et al.Breast cancer research and treatment. 1999, Vol 58, Num 2, pp 151-156, issn 0167-6806Article

Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot studySCHOLL, S. M; LIDEREAU, R; DE LA ROCHEFORDIERE, A et al.Breast cancer research and treatment. 1996, Vol 39, Num 3, pp 275-283, issn 0167-6806Article

Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosisSCHOLL, S. M; PALLUD, C; BEUVON, F et al.Journal of the National Cancer Institute. 1994, Vol 86, Num 2, pp 120-126, issn 0027-8874Article

Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancerSCHOLL, S. M; BASCOU, C. H; MOSSERI, V et al.British journal of cancer. 1994, Vol 69, Num 2, pp 342-346, issn 0007-0920Article

Cancer controlatéral du sein : métastase ou second cancer primitif ? = Contralateral breast cancer : metastasis or second primary cancer ?BROËT, P; DE LA ROCHEFORDIERE, A; SCHOLL, S. M et al.Bulletin du cancer. 1996, Vol 83, Num 10, pp 870-876, issn 0007-4551Article

Metachronous contralateral breast cancer as first event of relapseDE LA ROCHEFORDIERE, A; MOURET-FOURME, E; ASSELAIN, B et al.International journal of radiation oncology, biology, physics. 1996, Vol 36, Num 3, pp 615-621, issn 0360-3016Conference Paper

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery : preliminary results of a randomised trial : S6SCHOLL, S. M; FOURQUET, A; GARCIO-GIRALT, E et al.European journal of cancer. Part A. 1994, Vol 30, Num 5, pp 645-652Article

Age as prognostic factor in premenopausal breast carcinomaDE LA ROCHEFORDIERE, A; ASSELAIN, B; CAMPANA, F et al.Lancet (British edition). 1993, Vol 341, Num 8852, pp 1039-1043, issn 0140-6736Article

Neoadjuvant chemotherapy in operabla breast cancerSCHOLL, S. M; ASSELAIN, B; PALANGIE, T et al.European journal of cancer (1990). 1991, Vol 27, Num 12, pp 1668-1671, issn 0959-8049Article

Prevalence of human papillomavirus type 16 DNA in cervical carcinoma samples in East AngliaSCHOLL, S. M; KINSLEY PILLERS, E. M; ROBINSON, R. E et al.International journal of cancer. 1985, Vol 35, Num 2, pp 215-218, issn 0020-7136Article

  • Page / 1